 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || BOR15001L7 / Boreaderme
Trial primary completion date, Head-to-Head: An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis (clinicaltrials.gov) - Sep 8, 2020
P2, N=164, Not yet recruiting, Sponsor: Laboratoire Boreaderme Inc.
Trial primary completion date: Jul 2020 --> Jul 2021
- |||| BOR15001L7 / Boreaderme
New P2 trial, Head-to-Head: An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis (clinicaltrials.gov) - Jun 6, 2019
P2, N=164, Not yet recruiting, Sponsor: Laboratoire Boreaderme Inc.
- BOR15001L7 / Boreaderme
Enrollment open, Trial initiation date, Trial primary completion date: Study of a New Topical Natural Health Product for the Treatment of Herpes Labialis (clinicaltrials.gov) - Mar 9, 2017
P=N/A, N=40, Recruiting, Sponsor: Laboratoire Boreaderme Inc.
Trial primary completion date: Jul 2020 --> Jul 2021 Not yet recruiting --> Recruiting | Initiation date: Oct 2015 --> Jan 2016 | Trial primary completion date: Mar 2016 --> Sep 2017
- BOR15001L7 / Boreaderme
New trial: Study of a New Topical Natural Health Product for the Treatment of Herpes Labialis (clinicaltrials.gov) - Oct 23, 2015
P=N/A, N=40, Not yet recruiting, Sponsor: Laboratoire Boreaderme Inc.